Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    EHC 2022
    AES 2022
    WSC 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Headache

The burden of migraine: from  individuals to society 2:43
The burden of migraine: from individuals to society
Messoud Ashina • 23 Jun 2022
Pontine-hypothalamic interplay for predicting migraine progression 3:31
Pontine-hypothalamic interplay for predicting migraine progression
Roberta Messina • 13 Apr 2022
Future work on pharmacogenomic testing in migraine 1:01
Future work on pharmacogenomic testing in migraine
Yi-Chieh Chen • 5 Apr 2022
A set of metabolites differentiates ischemic stroke from stroke mimics 5:22
A set of metabolites differentiates ischemic stroke from stroke mimics
Steffen Tiedt • 12 Jul 2022
The promise of pharmacogenomics in migraine 1:34
The promise of pharmacogenomics in migraine
Yi-Chieh Chen • 9 Jun 2022
Influencing the endocannabinoid system in headache research 10:43
Influencing the endocannabinoid system in headache research
Tally Largent-Milnes • 13 Jun 2022
Pharmacogenomics in medicine and migraine treatment 2:51
Pharmacogenomics in medicine and migraine treatment
Yi-Chieh Chen • 9 Jun 2022
REGAIN trial of galcanezumab in chronic migraine 1:18
REGAIN trial of galcanezumab in chronic migraine
Uwe Reuter • 25 Jun 2022
A phosphoproteome analysis of migraine serum 9:34
A phosphoproteome analysis of migraine serum
Tally Largent-Milnes • 13 Jun 2022
Eptinezumab: the first approved infusion medication for migraine prevention 1:06
Eptinezumab: the first approved infusion medication for migraine prevention
Rami Apelian • 21 Jun 2022
Precision phenotyping in migraine using topological data analysis 3:29
Precision phenotyping in migraine using topological data analysis
Chia-Chun Chiang • 21 Jun 2022
AHS highlights: atogepant and zavegepant for migraine treatment 2:05
AHS highlights: atogepant and zavegepant for migraine treatment
Stewart Tepper • 17 Jun 2022
Future work on rimegepant for migraines 1:30
Future work on rimegepant for migraines
Richard Lipton • 13 Jun 2022
What makes migraine worse? 1:22
What makes migraine worse?
Amynah Pradhan • 20 Jun 2022
Future research topics in pediatric headache disorders 2:00
Future research topics in pediatric headache disorders
Serena Orr • 14 Jun 2022
Updates on lifestyle behaviors and migraine 3:56
Updates on lifestyle behaviors and migraine
Elizabeth Seng • 15 Jun 2022
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 17
  • Next
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy